MAGISNAT, a spin-off specializing in applying omics sciences to personalize lifestyles and dietary supplements, proudly announces its membership in the Gwinnett Chamber of Commerce. This strategic move aims to strengthen the company's presence in the international economic landscape, with a focus on technological growth and cross-sector collaboration.
Operating from Atlanta Tech Park, an innovation hub dedicated to advanced technologies, MAGISNAT benefits from an ideal environment to develop solutions grounded in a multi-omics approach. The company’s primary goal is to analyze individuals' genomic, proteomic, and metabolomic profiles to tailor both dietary supplementation and lifestyle recommendations. Applications range from nutritional programs for athletes to targeted interventions for seniors, sedentary individuals, or those with complex metabolic conditions.
Joining the Gwinnett Chamber of Commerce provides MAGISNAT with access to a well-established network of businesses and economic institutions. The Chamber's structure, which includes an exclusive private club for networking and high-level meetings, serves as a distinctive feature within the local entrepreneurial ecosystem. This platform facilitates knowledge exchange, access to strategic economic resources, and participation in regional economic development initiatives.
Technological Innovation: The Lipedema Patent
In conjunction with its membership in the Gwinnett Chamber, MAGISNAT has secured approval for the U.S. patent titled "Mast Cell Stabilizer with Sodium Cromoglycate-based Inhibitor for Preventing Lipedema Progression." This patent outlines a pharmaceutical inhibitor based on Sodium Cromoglycate, designed to stabilize mast cells and reduce histamine levels in treating lipedema.
The inhibitor can be administered orally or as a topical cream. Its primary mechanism of action focuses on preventing adipocyte proliferation by modulating mast cell activity. This approach aims to counteract the increase in adipose tissue mass and volume, offering a therapeutic method to manage disease progression and alleviate associated symptoms, including pain and inflammation.
The publication of this patent marks a significant contribution to pharmacological research on lipedema, introducing novel therapeutic options in a field currently characterized by limited treatment alternatives.
Growth and Development Strategies
MAGISNAT's participation in the Gwinnett Chamber of Commerce aligns with a growth strategy focused on collaboration with economic, academic, and technological partners. Access to local and international economic development programs, coupled with opportunities for advanced networking, creates an optimal environment for business expansion and integration with other biotechnology sector stakeholders.
The Chamber serves as a meeting point for businesses, institutions, and key stakeholders, fostering an environment conducive to knowledge sharing and targeted collaborations.
In a global economic context defined by increasing interdependence between science and industry, MAGISNAT's presence in the Gwinnett Chamber represents a strategic integration with significant potential benefits in terms of economic development, technological innovation, and optimization of production processes.
0 Comments